SEC Form 4 · accession 0001179110-18-006950
Strongbridge Biopharma plc · SBBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garheng Kong
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 8:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001634432
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $7.75 | May 15, 2018 | A | 40,000 | A | May 15, 2019 | May 15, 2028 | Common Stock | 40,000 | 40,000 | D |